Skip to main content

Caliper Teams with HistoRx on Protein Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it has struck an alliance with HistoRx to co-develop new tissue-based imaging and analysis solutions for protein biomarkers.

The collaboration will combine Caliper's Vectra automated, multiplex tissue imaging platform, with HistoRx's Aqua image analysis system. The firms expect the collaboration to advance the identification and validation of new drug targets and improve drug response monitoring.

Under the deal, Caliper will have exclusive worldwide distribution rights for integrated products in the life science research market. The firm also intend to explore collaborative opportunities in clinical research and diagnostics.

"We see an opportunity to bring a comprehensive solution to the research market to help expand scientists' options for capturing key disease signatures and to aid in the development of new drugs and new strategies to battle cancer," Caliper President and CEO Kevin Hrusovsky said in a statement.

Caliper said that it expects an Aqua-enabled Vectra platform to launch in August this year.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.